Advertisement
The combined company will be known as ConvaTec and will be led by currentConvaTec CEO, David Johnson. ConvaTec will have four business divisions:Ostomy Care, Wound Therapeutics, Continence & Critical Care, and InfusionDevices. Infusion Devices will continue to operate separately. As requiredby the European Competition Commission, the integration will not include theUnomedical Wound Care division, which will be divested within the next severalmonths.
Advertisement
"This is a tremendous day for our customers, our employees and ourbusiness," said David Johnson, CEO, ConvaTec. "As two global healthcareleaders, we are uniquely positioned to build on each other's strengths. Byjoining forces, our combined company will be able to offer our customersaround the world an unprecedented portfolio of comprehensive best-in-classsolutions."
With complementary portfolios in acute care and home healthcare, thecombined company will be a much larger driving force in the industry, with anexpanded offering of products and product-related services for customersaround the world. Unomedical's strong presence in hospitals and intensivecare, especially deep throughout Europe, will complement ConvaTec's existingstrengths in community and home-based care.
Johnson continued, "Together, we are poised for accelerated growth andinnovation. Most importantly, we share the same goal -- to improve the livesof patients and to support healthcare professionals globally."
About ConvaTec
For over 30 years, ConvaTec has been a pioneer in developing and marketinginnovative wound therapeutics and ostomy care products that have helpedimprove the lives of millions of people worldwide. Today, ConvaTec continuesto be at the forefront of the movement to change the way healthcareprofessionals are managing chronic and acute wounds, emphasizing theprinciples of advanced wound care management and evidence-based medicine.From its headquarters in Skillman, New Jersey, the company oversees more than3,500 employees in 91 countries serving patients and their healthcareprofessionals on six continents. ConvaTec is owned by Nordic Capital andAvista Capital Partners. For more information, please visit www.convatec.com.
About Unomedical
Unomedical is a leading provider of single-use medical devices with globaloperations. Within Hospital Care, Unomedical is one of Europe's leadingcompanies and it has strong niche positions overseas. Within InfusionDevices, Unomedical is a global market leader within infusion sets used bydiabetics on pump therapy. Based in Birkerod, Denmark, Unomedical has productdevelopment, manufacturing and sales offices worldwide and employs some 4,500employees in 14 countries. For more information, please visitwww.unomedical.com.Contacts Nimisha Savani ConvaTec Phone: 908-904-2522 Nimisha.Savani@convatec.com Punnie Donohue Weber Shandwick Phone: 212-445-8163 PDonohue@webershandwick.com Harry Levin OutCom Phone: +45 33 12 19 00 Levin@outcom.dk
SOURCE ConvaTec
